After One Dose of Gene Therapy Hemophilia B Patients Maintain Near-normal Levels of Clotting Factor
Published on in CHOP News, International Update
In a clinical trial led by a CHOP researcher, adult patients with hemophilia B were able to pursue daily activities without disabling bleeds.